John P. Schmid

John P. Schmid has an estimated net worth of $4.43 Million. This is based on reported shares across multiple companies, which include XERIS PHARMACEUTICALS INC, Trius Therapeutics Inc, Auspex Pharmaceuticals, Inc., Design Therapeutics, Inc., Poseida Therapeutics, Inc., ANAPTYSBIO, INC, Xeris Biopharma Holdings, Inc., Neos Therapeutics, Inc., Helix Acquisition Corp, BridgeBio Oncology Therapeutics, Inc., First Tracks Biotherapeutics, Inc., and Helix Acquisition Corp. III.

2026 was John P. Schmid's most active year for acquiring shares with 26 total transactions. John P. Schmid's most active month to acquire stocks was the month of March. 2011 was John P. Schmid's most active year for disposing of shares, totalling 18 transactions. John P. Schmid's most active month to dispose stocks was the month of December. 2025 saw John P. Schmid paying a total of $476,247.49 for 130,975 shares, this is the most they've acquired in one year. In 2013 John P. Schmid cashed out on 444,497 shares for a total of $2,971,336.18, their largest year based on trade value.